Literature DB >> 22445695

The vasodilatory effect of testosterone on renal afferent arterioles.

Yan Lu1, Yiling Fu, Ying Ge, Luis A Juncos, Jane F Reckelhoff, Ruisheng Liu.   

Abstract

BACKGROUND: Sex differences exist in a variety of cardiovascular and renal diseases, and testosterone may contribute to the discrepancy. Afferent arterioles (Af-Arts) are the major resistance vessels in the kidney, and they play an important role in the development of renal injury and hypertension.
OBJECTIVE: We sought to determine the acute effect and underlying mechanism(s) of action of testosterone on Af-Arts.
METHODS: The mRNA expression of androgen receptors (ARs) in microdissected Af-Arts was measured by reverse transcription-polymerase chain reaction (RT-PCR). An in vitro microperfusion model was used to measure the diameter of Af-Arts in mice. Nitric oxide (NO) was evaluated by an NO-sensitive fluorescent dye, 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate.
RESULTS: Testosterone had no effect on microperfused Af-Arts when added to the bath. Therefore, we preconstricted the Af-Arts to approximately 30% with norepinephrine (10(-6) M); administration of testosterone (10(-9)-10(-7) M) subsequently dilated the Af-Arts in a dose-dependent manner (P < 0.001; n = 7). The AR mRNA was expressed in microdissected Af-Arts measured by RT-PCR. An AR antagonist, flutamide (10(-5) M), totally blocked the testosterone (10(-8) M)-induced vasodilator effect. Mean (SEM) NO production of the Af-Art wall was increased when testosterone was added to the bath solution after norepinephrine treatment, from 278.4 (12.1) U/min to 351.2 (33.1) U/min (P < 0.05; n = 3). In the presence of NO inhibition with N(G)-nitro-L-arginine methyl ester (3 × 10(-4) M), the testosterone-induced dilatation was blunted compared with norepinephrine (P < 0.05).
CONCLUSIONS: Testosterone dilated preconstricted mouse Af-Arts in a dose-dependent manner by activation of ARs and partially mediated by NO.
Copyright © 2012 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22445695      PMCID: PMC3322301          DOI: 10.1016/j.genm.2012.02.003

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  38 in total

1.  Testosterone acts as a coronary vasodilator by a calcium antagonistic action.

Authors:  K M English; R D Jones; T H Jones; A H Morice; K S Channer
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

2.  Acute haemodynamic effects of testosterone in men with chronic heart failure.

Authors:  Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

Review 3.  Gender differences in the regulation of blood pressure.

Authors:  J F Reckelhoff
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

4.  Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation.

Authors:  A Q Ding; J N Stallone
Journal:  J Appl Physiol (1985)       Date:  2001-12

5.  Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel.

Authors:  V P Deenadayalu; R E White; J N Stallone; X Gao; A J Garcia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

6.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

Authors:  Joel Neugarten; Anjali Acharya; Sharon R Silbiger
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

Review 7.  Multiple actions of steroid hormones--a focus on rapid, nongenomic effects.

Authors:  E Falkenstein; H C Tillmann; M Christ; M Feuring; M Wehling
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

8.  Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats.

Authors:  Harish Vasudevan; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2011-09-06       Impact factor: 3.396

9.  Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels.

Authors:  Patcharin Tep-areenan; David A Kendall; Michael D Randall
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

10.  Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse.

Authors:  Richard D Jones; Peter J Pugh; Joanne Hall; Kevin S Channer; T Hugh Jones
Journal:  Eur J Endocrinol       Date:  2003-01       Impact factor: 6.664

View more
  16 in total

1.  Crucial role of androgen receptor in vascular H2S biosynthesis induced by testosterone.

Authors:  V Brancaleone; V Vellecco; D S Matassa; R d'Emmanuele di Villa Bianca; R Sorrentino; A Ianaro; M Bucci; F Esposito; G Cirino
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

2.  Effects of testosterone administration (and its 5-alpha-reduction) on parenchymal organ volumes in healthy young men: findings from a dose-response trial.

Authors:  T Gagliano-Jucá; E R Tang; S Bhasin; K M Pencina; S Anderson; H Jara; Z Li; K Melamud; S L Coleman; A Aakil; R R Almeida; G Huang; T G Travison; T W Storer; S Basaria
Journal:  Andrology       Date:  2017-07-13       Impact factor: 3.842

3.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

4.  Glucose dilates renal afferent arterioles via glucose transporter-1.

Authors:  Jie Zhang; Shan Jiang; Jin Wei; Kay-Pong Yip; Lei Wang; En Yin Lai; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

5.  Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes.

Authors:  Javier M Farias; Matias Tinetti; Marina Khoury; Guillermo E Umpierrez
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

6.  Identification and function of adenosine A3 receptor in afferent arterioles.

Authors:  Yan Lu; Rui Zhang; Ying Ge; Mattias Carlstrom; Shaohui Wang; Yiling Fu; Liang Cheng; Jin Wei; Richard J Roman; Lei Wang; Xichun Gao; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-21

7.  Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-α ratio and attenuating T-cell infiltration.

Authors:  Chetan N Patil; Kedra Wallace; Babbette D LaMarca; Mohadetheh Moulana; Arnaldo Lopez-Ruiz; Andrea Soljancic; Luis A Juncos; Joseph P Grande; Jane F Reckelhoff
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01

8.  Testosterone enhances tubuloglomerular feedback by increasing superoxide production in the macula densa.

Authors:  Yiling Fu; Yan Lu; Eddie Y Liu; Xiaolong Zhu; Gouri J Mahajan; Deyin Lu; Richard J Roman; Ruisheng Liu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-06       Impact factor: 3.619

9.  Androgen-STAT3 activation may contribute to gender disparity in human simply renal cysts.

Authors:  Min Liu; Yun-Fei Xu; Yuan Feng; Wei Zhai; Jian-Ping Che; Sheng-Qiang Xia; Guang-Chun Wang; Jun-Hua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

10.  NaHCO3 Dilates Mouse Afferent Arteriole Via Na+/HCO3- Cotransporters NBCs.

Authors:  Shan Jiang; Ximing Wang; Jin Wei; Gensheng Zhang; Jie Zhang; Peng Xie; Lan Xu; Lei Wang; Liang Zhao; Lingli Li; Christopher S Wilcox; Jianghua Chen; En Yin Lai; Ruisheng Liu
Journal:  Hypertension       Date:  2019-09-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.